Tri Locum Partners LP

CIK

1826434

Location

NEW YORK, NY

Portfolio Value

Small $813,224,115

Diversification

Diversified

Filing Date

Global Rank

#2,177 / 8,645 ▲ 100

Top Industry

Biotechnology 59.1%

3Y Alpha vs SPY

+3.7%

Period ended 52 days ago

Filed Aug 14, 2026 · 7d

23 quarters · since Dec 2020

Clone Performance

Aug 2023–Aug 2026 · vs SPY

Hypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.

Cloned portfolio

+98.0%

SPY

+73.6%

Annualised alpha

+5.4%

Max drawdown

−21.8%

Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends; a captured split can shorten the simulated window. It tracks 99% of reported value on average across 13 quarters. Past performance does not predict future results.

Portfolio Concentration

19 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

13.3%

−1.6 pts

Top 5

52.2%

+0.3 pts

Top 10

80.0%

−5.2 pts

HHI

784

Diversified−58

Portfolio Trend

23 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$813,224,115	19

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

9 positions

Ticker	Company	Δ Shares	Shares	Value
AXSM	Axsome Therapeutics, Inc.	+157,192	219,308	$53,680,019
DXCM	Dexcom Inc	+122,321	820,479	$55,259,260
TARS	Tarsus Pharmaceuticals, Inc.	+75,752	328,340	$20,665,719
VRTX	Vertex Pharmaceuticals Inc / Ma	+72,477	201,791	$100,235,643
JAZZ	Jazz Pharmaceuticals plc	+63,057	221,720	$53,427,868
LLY	ELI LILLY & Co	+14,737	76,532	$91,794,784
JNJ	Johnson & Johnson	+10,442	424,945	$107,923,281
ARGX	Argenx SE	+9,961	41,596	$38,591,520
ASND	Ascendis Pharma A/S	+3,408	258,740	$69,011,132
No positions match the current search.

Trimmed

Positions the filer reduced

6 positions

Ticker	Company	Δ Shares	Shares	Value
TEVA	Teva Pharmaceutical Industries Ltd	−274,173	746,835	$25,302,769
DFTX	Definium Therapeutics, Inc.	−206,592	162,996	$7,667,331
ISRG	Intuitive Surgical Inc	−105,267	47,983	$19,081,879
MDGL	Madrigal Pharmaceuticals, Inc.	−35,015	68,273	$36,659,187
DNTH	Dianthus Therapeutics, Inc. /DE/	−24,831	120,712	$11,767,005
UTHR	UNITED THERAPEUTICS Corp	−23,344	47,026	$25,480,097
No positions match the current search.

New Positions

Positions the filer opened this quarter

4 positions

Ticker	Company	Shares	Value
ELVN	Enliven Therapeutics, Inc.	866,716	$43,985,837
RVMD	Revolution Medicines, Inc.	151,822	$28,433,224
CYTK	Cytokinetics Inc	194,000	$16,526,860
BBNX	Beta Bionics, Inc.	493,344	$7,730,700
No positions match the current search.

Sold Out

Positions the filer fully exited

2 positions

Ticker	Company	Shares	Value
TMO	Thermo Fisher Scientific Inc.	132,413	$65,084,961
NUVL	Nuvalent, Inc.	308,506	$0
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

19 tracked positions · $813,224,115 total · filing declares 19 positions · $813,224,117 · as of Jun 30, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
JNJ	Johnson & Johnson Healthcare	Added	424,945	+10,442	$107,923,281	+6.5%	13.27%
VRTX	Vertex Pharmaceuticals Inc / Ma Healthcare	Added	201,791	+72,477	$100,235,643	+73.6%	12.33%
LLY	ELI LILLY & Co Healthcare	Added	76,532	+14,737	$91,794,784	+61.5%	11.29%
ASND	Ascendis Pharma A/S Healthcare	Added	258,740	+3,408	$69,011,132	+18.2%	8.49%
DXCM	Dexcom Inc Healthcare	Added	820,479	+122,321	$55,259,260	+26.0%	6.80%
AXSM	Axsome Therapeutics, Inc. Healthcare	Added	219,308	+157,192	$53,680,019	+411.3%	6.60%
JAZZ	Jazz Pharmaceuticals plc Healthcare	Added	221,720	+63,057	$53,427,868	+78.1%	6.57%
ELVN	Enliven Therapeutics, Inc. Healthcare	NEW	866,716	NEW	$43,985,837	NEW	5.41%
ARGX	Argenx SE Healthcare	Added	41,596	+9,961	$38,591,520	+67.1%	4.75%
MDGL	Madrigal Pharmaceuticals, Inc. Healthcare	Reduced	68,273	-35,015	$36,659,187	−32.2%	4.51%
RVMD	Revolution Medicines, Inc. Healthcare	NEW	151,822	NEW	$28,433,224	NEW	3.50%
UTHR	UNITED THERAPEUTICS Corp Healthcare	Reduced	47,026	-23,344	$25,480,097	−38.9%	3.13%
TEVA	Teva Pharmaceutical Industries Ltd Healthcare	Reduced	746,835	-274,173	$25,302,769	−17.7%	3.11%
TARS	Tarsus Pharmaceuticals, Inc. Healthcare	Added	328,340	+75,752	$20,665,719	+16.6%	2.54%
ISRG	Intuitive Surgical Inc Healthcare	Reduced	47,983	-105,267	$19,081,879	−73.0%	2.35%
CYTK	Cytokinetics Inc Healthcare	NEW	194,000	NEW	$16,526,860	NEW	2.03%
DNTH	Dianthus Therapeutics, Inc. /DE/ Healthcare	Reduced	120,712	-24,831	$11,767,005	−3.7%	1.45%
BBNX	Beta Bionics, Inc. Healthcare	NEW	493,344	NEW	$7,730,700	NEW	0.95%
DFTX	Definium Therapeutics, Inc. Healthcare	Reduced	162,996	-206,592	$7,667,331	+9.8%	0.94%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.